About Silicon Therapeutics
Silicon Therapeutics is a company based in Boston (United States) founded in 2016 by Lijun Sun was acquired by Roivant Sciences in February 2021.. Silicon Therapeutics has raised $15 million across 2 funding rounds from investors including Roivant Sciences and Chengwei Capital. The company has 61 employees as of December 31, 2022. Silicon Therapeutics offers products and services including Immunovant, Priovant, and Pulmovant. Silicon Therapeutics operates in a competitive market with competitors including Insitro, Certara, HotSpot Therapeutics, Precision Neuroscience and CytoReason, among others.
- Headquarter Boston, United States
- Employees 61 as on 31 Dec, 2022
- Founders Lijun Sun
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Silicon Insite, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15 M (USD)
in 2 rounds
-
Latest Funding Round
$15 M (USD), Series A
Oct 19, 2016
-
Investors
Roivant Sciences
& 1 more
-
Employee Count
61
as on Dec 31, 2022
-
Acquired by
Roivant Sciences
(Feb 26, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Silicon Therapeutics
Silicon Therapeutics offers a comprehensive portfolio of products and services, including Immunovant, Priovant, and Pulmovant. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Advances therapies for autoimmune diseases through targeted treatments.
Develops targeted therapies for severe autoimmune conditions.
Focuses on transforming treatments for pulmonary diseases.
Unlock access to complete
Unlock access to complete
Leadership Team
24 people
Finance and Accounting
11 people
Board Team
9 people
Senior Team
9 people
Software Development Team
7 people
Advisor Team
6 people
Human Resources and Administration
6 people
Head Team
5 people
Unlock access to complete
Funding Insights of Silicon Therapeutics
Silicon Therapeutics has successfully raised a total of $15M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $15 million completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $15.0M
-
First Round
First Round
(26 Sep 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2016 | Amount | Series A - Silicon Therapeutics | Valuation | Chengwei Capital |
|
| Sep, 2016 | Amount | Debt – Conventional - Silicon Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Silicon Therapeutics
Silicon Therapeutics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Roivant Sciences and Chengwei Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Chengwei Capital is recognized as an early venture capital firm in China.
|
Founded Year | Domain | Location | |
|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Silicon Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Silicon Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Silicon Therapeutics Comparisons
Competitors of Silicon Therapeutics
Silicon Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, Certara, HotSpot Therapeutics, Precision Neuroscience and CytoReason, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Provider of a platform for in silico drug discovery and consulting services
|
|
| domain | founded_year | HQ Location |
Developer of a platform for protein function analysis
|
|
| domain | founded_year | HQ Location |
Brain-computer interfaces developed for medical treatment and drug development.
|
|
| domain | founded_year | HQ Location |
Immune system-based drugs are discovered via biological data analytics.
|
|
| domain | founded_year | HQ Location |
Synthetic biology tools are developed via genetic code recoding techniques.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Silicon Therapeutics
Frequently Asked Questions about Silicon Therapeutics
When was Silicon Therapeutics founded?
Silicon Therapeutics was founded in 2016.
Where is Silicon Therapeutics located?
Silicon Therapeutics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Silicon Therapeutics a funded company?
Silicon Therapeutics is a funded company, having raised a total of $15M across 2 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $250K, raised on Sep 26, 2016.
How many employees does Silicon Therapeutics have?
As of Dec 31, 2022, the latest employee count at Silicon Therapeutics is 61.
What does Silicon Therapeutics do?
Silicon Therapeutics was founded in 2016 in Boston, United States, within the biotechnology sector. In silico models of human drug targets are constructed to design novel therapeutics. The proprietary INSITE platform is utilized for targeted engineering efforts. Operations focus on computational drug discovery, with applications in pharmaceutical development across the region.
Who are the top competitors of Silicon Therapeutics?
Silicon Therapeutics's top competitors include Insitro, HotSpot Therapeutics and Precision Neuroscience.
What products or services does Silicon Therapeutics offer?
Silicon Therapeutics offers Immunovant, Priovant, and Pulmovant.
Who are Silicon Therapeutics's investors?
Silicon Therapeutics has 2 investors. Key investors include Roivant Sciences, and Chengwei Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.